Free Trial
NASDAQ:PLSE

Pulse Biosciences (PLSE) Stock Price, News & Analysis

Pulse Biosciences logo
$17.98 +0.19 (+1.07%)
(As of 12/20/2024 05:31 PM ET)

About Pulse Biosciences Stock (NASDAQ:PLSE)

Key Stats

Today's Range
$17.50
$18.53
50-Day Range
$14.56
$21.40
52-Week Range
$6.59
$22.69
Volume
166,773 shs
Average Volume
200,640 shs
Market Capitalization
$1.11 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Pulse Biosciences Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
36th Percentile Overall Score

PLSE MarketRank™: 

Pulse Biosciences scored higher than 36% of companies evaluated by MarketBeat, and ranked 731st out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Pulse Biosciences.

  • Price to Book Value per Share Ratio

    Pulse Biosciences has a P/B Ratio of 22.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    12.40% of the float of Pulse Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Pulse Biosciences has a short interest ratio ("days to cover") of 12.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Pulse Biosciences has recently increased by 1.92%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Pulse Biosciences does not currently pay a dividend.

  • Dividend Growth

    Pulse Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    12.40% of the float of Pulse Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Pulse Biosciences has a short interest ratio ("days to cover") of 12.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Pulse Biosciences has recently increased by 1.92%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Pulse Biosciences has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 16 news articles for Pulse Biosciences this week, compared to 2 articles on an average week.
  • Search Interest

    3 people have searched for PLSE on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Pulse Biosciences to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pulse Biosciences insiders have bought 120.65% more of their company's stock than they have sold. Specifically, they have bought $1,921,835.00 in company stock and sold $871,000.00 in company stock.

  • Percentage Held by Insiders

    71.50% of the stock of Pulse Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    76.95% of the stock of Pulse Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Pulse Biosciences' insider trading history.
Receive PLSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter.

PLSE Stock News Headlines

Vacuum up cash with these special trades?
Have you ever heard about a “volatility vacuum?” Most people haven’t. It all revolves around this formula right here. Now, the most important thing is that this equation — when applied to certain tickers at a certain time each month —- can trigger these “volatility vacuums.” And when that happens, anyone has the shot at sucking out payouts of $290, $350, even $1,350 in as little as 24 hours. (With just a $1k starting stake!) Granted, there were smaller wins and those that did not work out but best of all, we can know exactly when these opportunities will hit. I’ve used this info to create a Cash Calendar that lays out the precise dates of these payouts.
Pulse Biosciences Inc.
See More Headlines

PLSE Stock Analysis - Frequently Asked Questions

Pulse Biosciences' stock was trading at $12.24 on January 1st, 2024. Since then, PLSE stock has increased by 46.9% and is now trading at $17.98.
View the best growth stocks for 2024 here
.

Pulse Biosciences, Inc. (NASDAQ:PLSE) posted its earnings results on Wednesday, October, 30th. The company reported ($0.21) EPS for the quarter.

Pulse Biosciences (PLSE) raised $20 million in an initial public offering on Wednesday, May 18th 2016. The company issued 5,000,000 shares at $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.

Top institutional shareholders of Pulse Biosciences include State Street Corp (0.75%), Geode Capital Management LLC (0.74%), Charles Schwab Investment Management Inc. (0.24%) and Westside Investment Management Inc. (0.09%). Insiders that own company stock include Mitchell E Levinson, Burke Thomas Barrett and Kevin Patrick Danahy.
View institutional ownership trends
.

Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pulse Biosciences investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), Novo Nordisk A/S (NVO) and Jabil (JBL).

Company Calendar

Last Earnings
10/30/2024
Today
12/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PLSE
Fax
N/A
Employees
140
Year Founded
N/A

Profitability

Net Income
$-42,210,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$700,000.00
Book Value
$0.81 per share

Miscellaneous

Free Float
17,532,000
Market Cap
$1.11 billion
Optionable
Optionable
Beta
1.78
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

This page (NASDAQ:PLSE) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners